The chemotherapy duo performed better than expected as a stand-in for bacillus Calmette-Guérin (BCG), which is the gold standard for non–muscle-invasive bladder cancer but is currently in short supply.
Medscape Medical News
Gemcitabine-Docetaxel Effective Alternative to BCG in NMIBC
